<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Rohrer JD</submitter><funding>Medical Research Council</funding><funding>National Institute for Health Research (NIHR)</funding><funding>Wellcome Trust</funding><pagination>603-10</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC2931766</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>75(7)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Despite recent work, the nosology of nonfluent primary progressive aphasia (PPA) remains unresolved.&lt;h4>Methods&lt;/h4>We describe a clinical and neurolinguistic cross-sectional analysis of a cohort of 24 patients with nonfluent PPA. Patients were initially classified based on analysis of spontaneous speech into 4 groups: apraxia of speech (AOS)/agrammatism (10 patients); AOS/no agrammatism (4 patients); no AOS/agrammatism (3 patients); no AOS/no agrammatism (7 patients). These groups were further characterized using a detailed neurolinguistic and neuropsychological battery. Parkinsonism was present in 3/10 patients in the AOS/agrammatism group. All patients in the no AOS/agrammatism group had mutations in the progranulin (GRN) gene, while 5/7 cases in the no AOS/no agramma</pubmed_abstract><journal>Neurology</journal><pubmed_title>Syndromes of nonfluent primary progressive aphasia: a clinical and neurolinguistic analysis.</pubmed_title><pmcid>PMC2931766</pmcid><funding_grant_id>NF-SI-0508-10123</funding_grant_id><funding_grant_id>G0401247</funding_grant_id><pubmed_authors>Warren JD</pubmed_authors><pubmed_authors>Rohrer JD</pubmed_authors><pubmed_authors>Rossor MN</pubmed_authors></additional><is_claimable>false</is_claimable><name>Syndromes of nonfluent primary progressive aphasia: a clinical and neurolinguistic analysis.</name><description>&lt;h4>Background&lt;/h4>Despite recent work, the nosology of nonfluent primary progressive aphasia (PPA) remains unresolved.&lt;h4>Methods&lt;/h4>We describe a clinical and neurolinguistic cross-sectional analysis of a cohort of 24 patients with nonfluent PPA. Patients were initially classified based on analysis of spontaneous speech into 4 groups: apraxia of speech (AOS)/agrammatism (10 patients); AOS/no agrammatism (4 patients); no AOS/agrammatism (3 patients); no AOS/no agrammatism (7 patients). These groups were further characterized using a detailed neurolinguistic and neuropsychological battery. Parkinsonism was present in 3/10 patients in the AOS/agrammatism group. All patients in the no AOS/agrammatism group had mutations in the progranulin (GRN) gene, while 5/7 cases in the no AOS/no agramma</description><dates><release>2010-01-01T00:00:00Z</release><publication>2010 Aug</publication><modification>2025-04-22T05:12:50.093Z</modification><creation>2019-03-27T00:33:46Z</creation></dates><accession>S-EPMC2931766</accession><cross_references><pubmed>20713949</pubmed><doi>10.1212/WNL.0b013e3181ed9c6b</doi><doi>10.1212/wnl.0b013e3181ed9c6b</doi></cross_references></HashMap>